Aberrant pancreas is defined as pancreatic tissue present outside of the pancreas and is often found incidentally during esophagogastroduodenoscopy. Obtaining sufficient tissue to differentiate aberrant pancreas from other subepithelial lesions is sometimes difficult. Due to the lack of a definitive diagnosis, patients often undergo unnecessary surgery. We herein report the first case of aberrant pancreas in which the concomitant use of needle-based probe confocal laser endomicroscopy and fine-needle aspiration supported the final diagnosis. Needle-based probe confocal laser endomicroscopy provides a real-time in vivo histopathology evaluation and may be a feasible means of diagnosing aberrant pancreas.
Introduction
Although aberrant pancreas is classically seen in the gastric antrum during routine esophagogastroduodenoscopy (EGD) as a subepithelial lesion (SEL), a standard biopsy examination with EGD usually cannot differentiate from other SELs. They have similar appearances but require different treatment strategies. A gastrointestinal stromal tumor (GIST) carries a risk of malignant transformation and is an indication for surgical resection. Conversely, aberrant pancreas does not require any treatment or follow-up in the absence of symptoms. An effective way of diagnosing aberrant pancreas would therefore be helpful in stratifying patient management.
Endoscopic ultrasonography (EUS) is commonly used to assess gastric SELs, but EUS findings cannot establish the diagnosis. Rosch et al. reported that the sensitivity and specificity of EUS for differentiating between malignant and benign submucosal tumors were only 64% and 80%, respectively (1). Karaca et al. reported that EUS alone had an accuracy rate of 30.8% and 66.7%, respectively, for the diagnosis of neoplastic and non-neoplastic lesions (2) .
EUS-fine-needle aspiration (EUS-FNA) is performed to diagnose gastric SELs. Obtaining a histopathological diagnosis by EUS-FNA seems to be a low-invasive and reasonable approach. However, the sensitivities of EUS-FNA have been reported to range from 65-79% in some prospective studies (3) (4) (5) (6) (7) . EUS-FNA therefore remains inadequate for accurately diagnosing SEL and sometimes leads to a misdiagnosis, with the lesion being resected as GIST (8) . Furthermore, EUS-FNA requires several punctures to obtain a large enough tissue sample for a diagnosis. Attwell et al. reported two cases of acute ectopic pancreatitis after two to six passes of EUS-FNA for aberrant pancreas in nine patients (9) . Although various methods, such as endoscopic submucosal-mucosal resection and a trucut biopsy, have been reported (2, 4, 10) , their accuracies are not superior to that of EUS-FNA. A less invasive and more sensitive method of diagnosing aberrant pancreas is therefore desir-Intern Med 57: 2827-2831, 2018 DOI: 10.2169/internalmedicine.0449-17 
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able. Needle-based confocal laser endomicroscopy (nCLE) is a newly developed modality that allows for a real-time optical biopsy at the time of EUS. It is widely used in the assessment of pancreatic cysts (11, 12) . We herein report a case of aberrant pancreas diagnosed by nCLE.
Case Report
The patient involved in this study gave his written informed consent authorizing the use and disclosure of his protected health information.
A 47-year-old man was referred to our medical center for the investigation of an SEL that had been detected on EGD during a medical checkup. He had no remarkable medical history and no symptoms. EGD revealed an 18-mm SEL with its umbilication on the grater curvature of the antrum (Fig. 1 ). There was a high-density mass on the same lesion on contrast-enhanced computed tomography. EUS showed a hypoechoic mass with a partially high echoic lesion, arising from the third layer of the gastric wall (Fig. 2) .
The AQ-Flex 19 probe (Mauna Kea Technologies, Paris, France) was preloaded into a 19-gauge EUS needle and locked into position, with 2 mm being exposed beyond the tip (Fig. 3) . This SEL was punctured, and 2 mL of fluorescein sodium was injected. nCLE findings revealed a dark lobular stricture similar to "coffee beans," which is typical for normal pancreas acinus (13, 14) (Fig. 4) . Then, with the nCLE probe, EUS-FNA was performed using the slow pull method. There were no complications. The cytology result was compatible with pancreatic acinus (Fig. 5) . We diagnosed the patient with aberrant pancreas based on EGD, EUS, cytology and nCLE findings. 
Discussion
Aberrant pancreatic tissue is typically hypoechoic and limited to the third (submucosal) layer, sometimes extending to the fourth (muscle) layer (15) . The most common site of the aberrant pancreas is in the gastrointestinal tract, such as the stomach, especially in the antrum (38-26%), duodenum (28-36%), and jejunum (16%) (16, 17) . The characteristic EUS features of an aberrant pancreas are indistinct borders, lobulated margins, the presence of anechoic duct-like structures, a mural growth pattern, and localization within two or more layers (18, 19) .
EUS-FNA has been performed to obtain pathological diagnoses from SELs, but the accuracies of such diagnoses are not high enough (Table) (3-5, 7, 20-26) . Like GISTs, aberrant pancreas, leiomyoma and schwannoma, the cells comprising gastric SELs are so strongly connected that it is difficult to obtain sufficient tissue to make a diagnosis using EUS-FNA. An alternative modality for making a histological diagnosis of SELs is therefore needed. nCLE enables a real-time in vivo histopathology evaluation during EUS. With nCLE, cellular imaging and the evaluation of tissue architecture at the focal plane can be performed during endoscopy (27) . Fluorescein is usually administered immediately before imaging. Optimum images are obtained within 30 seconds to 8 minutes after injection but can be interpreted for as long as 60 minutes (28) . A normal pancreas looks similar to "coffee beans", an appearance that corresponds to the histological structures of acinus (13, 14) . Given our findings, nCLE seems to be a feasible method for diagnosing aberrant pancreas, overcoming difficulties in obtaining sufficient tissue for a diagnosis. The only adverse event reported to be associated with nCLE is allergic reactions to intravenous fluorescein, but most such cases are mild. This case represents the first experience in which nCLE led to a gastric SEL being diagnosed as aberrant pancreas. nCLE can increase the diagnostic yield of aberrant pancreas and may reduce the rate of post-FNA complications, such as pancreatitis and hemorrhaging, as it requires fewer passes and punctures than FNA. Indeed, one pass is enough when specific features are observed on nCLE, as obtaining enough tissue from gastric SEL for a diagnosis is usually difficult with EUS-FNA even with multiple passes. In the present case, we performed only one pass for EUS-FNA along with nCLE by a slow pull method without ROSE. We were able to identify the typical features of pancreatic acinus on nCLE; this suggests that multiple FNA procedures may become unnecessary and that omitting ROSE may be feasible, allowing for the repeated use of specimens for cytology. Case series are needed to confirm the diagnostic performance of nCLE for detecting aberrant pancreas.
In conclusion, although EUS-FNA is the widely used gold standard for the histological and cytological diagnosis of aberrant pancreas, nCLE may be a less-invasive diagnostic modality or at least provide an additional evaluation method.
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